[1]
L. S. Raissa Costa Leite and M. A. . Estrin, “Cardiovascular risk associated with the use of selective COX-2 inhibitors: a systematic review”, Interamerican Journal of Health Sciences, vol. 2, p. 118, Dec. 2022, doi: 10.59471/ijhsc2022118.